cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Asmat Burhan
Contact Email
asmatburhan1@gmail.com
Phone
+6285746157782
Journal Mail Official
indahnoni138@gmail.com
Editorial Address
Alana Crown Blok B16, Samparangin, Teluk, Purwokerto Selatan, Banyumas.
Location
Kab. banyumas,
Jawa tengah
INDONESIA
Journal of Wound Research and Technology
Published by Indonesian Science Media
ISSN : -     EISSN : 30380043     DOI : 10.70196
Core Subject : Health,
Medicine & Pharmacology Nursing
Journal of Wound Research and Technology is an essential source of information for all wound care professionals. We publish all aspects of the promotion, prevention, and treatment of wounds and associated skin conditions to improve patient care. With topics spanning surgery, endocrinology, dermatology, vascular, oncology, nursing, technology, radiotherapy, physical therapy, occupational therapy, modality therapy, and podiatry, the Journal of Wound Research and Technology continues to be the premier wound care journal for a wide range of healthcare professionals such as physicians, surgeons, nurses, midwives, podiatrists, physical therapists, radiotherapists, oncologists and occupational therapists.
Arjuna Subject : Profesi Kesehatan - Profesi Kesehatan (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 2 No. 1 (2025): November - May 2025" : 5 Documents clear
Effectiveness of Comprehensive Therapy vs. Standard Treatment in Diabetic Foot Ulcer Healing: A Retrospective Cohort Study Ana Patricia Bautista; Inoue Mei Haruka; Nguyen Thi Mai; Kim Hoa Ngan; Chole Scarlet Charlotte
Journal of Wound Research and Technology Vol. 2 No. 1 (2025): November - May 2025
Publisher : Indonesian Science Media

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70196/jwrt.v2i1.42

Abstract

Background: The Diabetic foot ulcer (DFU) is the tip of a very significant complication of diabetes mellitus (DM), often leading to grave outcomes in infection and eventually amputation with increased mortality. Many factors mess up the healing of DFUs: neuropathy, peripheral arterial disease, and hyperglycemia, just to mention a few. The best published healing outcomes have been reported with an integrated therapy consisting of Health care, intensive glucose management, wound care, and psychosocial support, although standard treatments provide only wound care and blood glucose management. Purpose: This study will check how effective complete therapy is in improving DFU faster than normal treatment. It will also examine how blood sugar control, insulin help, and mental support affect wound healing. Methods: A Cohort of 360 DFU patients from Seamen’s Hospital Manila was analyzed. Patients were divided into two groups: 180 received standard treatment and 180 received comprehensive therapy. Comprehensive therapy included intensive glucose control plus advanced wound care and psychosocial support. Healing success is defined as complete wound closure within 12 weeks. Statistical analyses, including chi-square tests, t-tests, and Cox proportional hazards regression, were performed to evaluate the impact of different factors on wound healing. Results: The comprehensive therapy group did markedly better, with an 85% healing success rate and average healing time of 8.3 weeks, compared to 55% and 11.7 weeks in the standard treatment group (p < 0.001). Multivariate analysis showed that glycemic control (HbA1c < 7%) turned out to be a significant predictor of faster healing as well as insulin therapy (HR =1.60 and HR =1.38, respectively). Psychosocial support also contributed positively to healing outcomes. Conclusion: Total treatment, covering wound care, blood sugar control, and mental social help, greatly speeds up DFU healing and cuts down the time taken to heal. This way should be called the best method for handling DFU and improving patient results.
Efficacy of Bioactive Dressings Compared to Passive Dressings in Promoting Wound Healing in Diabetic Foot Ulcers: A Randomized Controlled Trial Supansa Srisawat; Nattay Kittipong; Rungnapa Pimchanok; Nur Aisyah binti Hassan; Ain Syuhada binti Salleh; Indah Susanti; Asmat Burhan
Journal of Wound Research and Technology Vol. 2 No. 1 (2025): November - May 2025
Publisher : Indonesian Science Media

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70196/jwrt.v2i1.43

Abstract

Background: Diabetic foot ulcers (DFU) are a major complication of diabetes, leading to significant morbidity, increased healthcare costs, and a higher risk of amputations. Traditional wound care methods, such as passive dressings, have limitations in promoting faster healing and infection control. Bioactive dressings, which include antimicrobial and regenerative components, have shown promise in improving wound healing outcomes in DFU patients, but robust evidence comparing their efficacy to passive dressings in clinical practice remains scarce. Purpose: To evaluate the efficacy of bioactive dressings compared to passive dressings in promoting wound healing in patients with diabetic foot ulcers. Method: A randomized controlled trial was conducted in a single center, enrolling 90 adults with chronic DFUs. Participants were randomly assigned to receive either bioactive dressings (n=45) or passive dressings (n=45) for a 3-month treatment period. Inclusion criteria included adults aged 18–75 years with DFUs of at least 6 weeks duration and Wagner grade 2 or higher ulcers. The primary outcome was wound size reduction, assessed at baseline, 1 month, 2 months, and 3 months. Secondary outcomes included wound depth, infection control, epithelialization, and granulation. Results: At 1 month, the bioactive dressing group showed a significantly greater reduction in wound size compared to the passive dressing group (mean reduction 45% vs. 30%, p=0.003). Bioactive dressings also demonstrated superior infection control (p<0.001) and promoted faster epithelialization (p=0.022) and granulation (p=0.015). The control group exhibited slower healing rates and less pronounced improvements in secondary outcomes. Conclusions: Bioactive dressings significantly improve wound healing, infection control, and tissue regeneration in patients with diabetic foot ulcers compared to passive dressings. These findings support the integration of bioactive dressings as an effective treatment option in DFU management, particularly in the early stages of wound healing. Further studies with longer follow-up are needed to assess long-term outcomes
Exploring the Determinants of Diabetic Foot Ulcer Healing: A 12-Month Longitudinal Study Hanan Ansari; Intan Habibi; Munafirah Munafirah
Journal of Wound Research and Technology Vol. 2 No. 1 (2025): November - May 2025
Publisher : Indonesian Science Media

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70196/jwrt.v2i1.44

Abstract

Background: Diabetic foot infections (DFI) are a major complication of diabetes mellitus, contributing significantly to morbidity, amputation, and mortality. The healing process of diabetic foot ulcers (DFU) is influenced by multiple factors, including glycemic control, smoking status, and comorbidities such as neuropathy and peripheral artery disease. While cross-sectional studies have explored these factors, longitudinal studies are needed to observe how these variables affect the healing process over time. Purpose: To identify clinical, demographic, and lifestyle factors that influence the healing of diabetic foot infections over 12 months in patients at Hospital Nurhayati Garut. Methods: This prospective longitudinal study included 130 diabetic patients diagnosed with type 1 or type 2 diabetes mellitus and a diabetic foot ulcer of Wagner grade 2 or higher. Patients were followed over 12 months with data collection at baseline, 3, 6, and 12 months. Variables collected included demographics (age, sex), clinical characteristics (glycemic control, smoking status, infection severity, comorbidities), and treatment regimens. Kaplan-Meier survival analysis, Cox proportional hazards regression, and Generalized Estimating Equations (GEE) were used to analyze predictors of wound healing. Results: The mean age of participants was 58.7 years, with 53.8% male and 65.4% having type 2 diabetes. Smoking was present in 38.5% of patients. The analysis revealed that increased HbA1c levels (hazard ratio [HR], 1.22; 95% CI, 1.10-1.35) and smoking (HR, 0.58; 95% CI, 0.40-0.83) were significant predictors of delayed wound healing. Older age (HR, 1.04; 95% CI, 1.02-1.06) was also associated with a longer time to healing. Infection severity did not show a significant impact on healing. Advanced wound care therapies demonstrated a 10% reduction in healing time compared to standard care (p = 0.04). Conclusion: Glycemic control, smoking cessation, and age were significant predictors of wound healing in diabetic foot ulcers. The findings emphasize the importance of managing modifiable risk factors, particularly glycemic control and smoking, to improve healing outcomes in diabetic patients. Advanced wound care therapies were beneficial, but optimal outcomes require comprehensive management addressing lifestyle factors.
Healing at a Distance: A Cross-Sectional Study on the Impact of Telewoundcare in Burn Recovery Juris Jansons; Ilze Berzina; Piotr Nowak
Journal of Wound Research and Technology Vol. 2 No. 1 (2025): November - May 2025
Publisher : Indonesian Science Media

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70196/jwrt.v2i1.45

Abstract

Background: Burn injuries, especially first-degree burns, remain a significant global health issue. Comorbidities such as diabetes require careful attention to wounds for successful recovery. Telewoundcare, a novel remote wound care system, has been proposed as a potential improvement in wound care outcomes. However, its use on burn wounds, especially in patients with chronic conditions, has not been sufficiently studied. Purpose: This study sought to assess the outcome of using Telewoundcare on first-degree burns at Liepaja Regional Hospital, Latvia, and compare it to the outcomes of traditional care. The study also aimed to assess the impact of smoking, diabetes, hypertension, and nutritional status as comorbidities on the healing of burn wounds. Methods: The study used a sample of 70 burning adult patients with first-degree burns. The patients were separated into two groups, one utilizing Telewoundcare and the other using traditional care. Patient data regarding smoking, comorbid conditions, and nutrition were recorded. The primary outcome measured was burn wound healing 1, 2, and 3 months post-treatment, through assessment of wounds visually and measuring the healing time. Results: The results revealed that smoking wishing caused substantial delays in wound healing, mostly in the Telewoundcare subgroup (OR=1.85, p=0.03). Conversely, no significant differences were detected in healing outcomes across stratified treatment groups for factors such as age, nutritional level, or accompanying illness (p>0.05). Although Telewoundcare was suitable for the management of first-degree burns, it was not more effective than conventional care in this study. Conclusions: While Telewoundcare demonstrated an ability to expand access to burn care, it did not surpass conventional care in healing outcomes. The most significant determinant of wound healing was the patient's smoking status. More research is needed with larger populations and longer durations to adequately evaluate the sustained impact of Telewoundcare on burn wound treatment over time
Longitudinal Analysis of Silver Alginate Use for mammary wound cancer and Public Awareness Wang Xiaoming; Fujimoko Akito; Li Mei
Journal of Wound Research and Technology Vol. 2 No. 1 (2025): November - May 2025
Publisher : Indonesian Science Media

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70196/jwrt.v2i1.46

Abstract

Background: Managing chronic wounds is particularly relevant in the management of oncology patients. Silver alginate has potential in the prevention of infection and promotion of healing in chronic wounds; however, its application in mammary wound cancer is warranted for further research examination. Purpose: To assess the clinical outcomes and public perception influence on treatment uptake of silver alginate in mammary wound cancer. Methods: The longitudinal study conducted at Tianjin TEDA Hospital from January 2022 to February 2024 included a sample of 62 patients suffering from breast cancer with wound complications. Each patient received silver alginate in addition to conventional wound care. Information relating to age, wound area, infection, and exudate was documented at the start and during the follow-up visits. Dressings were applied and replenished according to clinical need. Key outcomes consisted of the level of wound repair, infection management, and clinical application with holistic guideline synthesis. A secondary criterion was societal interest through Google Trends monitoring. Findings: The data demonstrate that the use of silver alginate promoted wound healing with an increase of 45.7% in prescriptions within the study period. Furthermore, public awareness, as estimated by online searches, had a noteworthy correlation (r = 0.92, 95% CI, 0.89 – 0.95; P < .001) with prescription rates. which was significantly positive. By February 2024, wound care specialists constituted 45.6% of prescriptions, a remarkable increase from 28.3% in early 2022. Conclusions: Silver alginates have significant promise in the treatment of mammary wounds for cancer patients. There is a strong correspondence between public awareness, quantified through search data, and the adoption of silver alginate in the clinic, suggesting that more public awareness could help improve the treatment’s adoption.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue Vol. 2 No. 2 (2025): June - October 2025 Vol. 2 No. 1 (2025): November - May 2025 Vol. 1 No. 2 (2024): June - October 2024 Vol. 1 No. 1 (2024): November - May 2024